Synopsis: In India’s aromatic chemical market, which includes synthetic fragrance molecules, essential oils and upstream intermediates that support the perfume and FMCG industries around the world, five companies are gaining prominence: Privi Speciality Chemicals...
Synopsis: Denta Water shares fell 12% despite reporting an order book of Rs 841 crore, higher than its market cap, as weak Q3 execution and profit decline weighed on sentiment. Investors appeared concerned about revenue conversion pace, L1 orders awaiting approvals,...
Synopsis: Adani Power shares fell 6% after legal developments surrounding its proposed Uttar Pradesh thermal power project created uncertainty. Although the Supreme Court did not stay the project, the ongoing environmental challenge and regulatory scrutiny triggered...
Synopsis: Biocon shares gained after Q3 FY26 PAT surged 475% YoY, driven by improved profitability and steady revenue growth. Biosimilars remained the largest contributor, accounting for 59% of revenue. Strategic integration of Biocon Biologics and recent...
Synopsis: Cohance Lifesciences shares plunged 8% after reporting an 81% YoY fall in Q3 FY26 PAT, impacted by revenue decline, margin compression, customer-led inventory destocking, and regulatory disruptions at its Nacharam facility. Revised FY26 guidance and...
Synopsis: Puravankara shares surged 9% after the company reported a return to profitability in Q3 FY26, posting a Rs 58 crore profit after five consecutive weak quarters. Strong execution, improved handovers, robust revenue growth, and healthy collections signalled a...
Synopsis: Muthoot Finance shares plunged 12% despite reporting a 103% YoY jump in Q3 FY26 PAT, as investors reacted to rising bad debts written off, stress in its microfinance subsidiary, declining capital adequacy, and heavy dependence on elevated gold prices,...
Synopsis: Angel One and Groww delivered contrasting performances in Q3 FY26. Angel One led in revenue scale with Rs 1,335 crore in income, while Groww outperformed on profitability and asset aggregation, reporting higher EBITDA margins and Rs 3 trillion in customer...
Synopsis: Brokerages remain constructive on Divi’s Laboratories despite near-term profit moderation. While Q3FY26 revenue rose 12% YoY to Rs 2,604 crore, PAT marginally declined to Rs 583 crore. Jefferies and HSBC see strong upside driven by custom synthesis growth,...
